Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatoses × Percutaneous Collagen Induction × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatoses 1

Interventions

mirdametinib 3 Surveys and Questionnaires 2 Imatinib Mesylate 2 tipifarnib 1 talimogene laherparepvec 1 pirfenidone 1 nilotinib 1 emvododstat 1 diphenylcyclopropenone 1 cabozantinib 1 binimetinib 1 Sunitinib 1 Sirolimus 1 Sevoflurane 1 Propofol 1 Percutaneous Collagen Induction 1 Nitrous Oxide 1 Magnetic Resonance Spectroscopy 1 Lidocaine 1 Lasers, Solid-State 1 Lasers 1 Glycopyrrolate 1 Dexmedetomidine 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01682811 2021-06-18

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Medical College of Wisconsin

Phase 1 Completed

20 enrolled 11 charts

Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon ⚡